Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements (Tables)

v3.6.0.2
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2016
Fair Value Disclosures [Abstract]  
Financial Assets and Liabilities Carried at Fair Value on Recurring Basis

The following tables set forth the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as follows (in thousands):

 

 

 

Fair Value Measurements at December 31, 2016 Using

 

 

 

Quoted Prices in

Active Markets for

Identical Assets

 

 

Significant Other

Observable

Inputs

 

 

Significant

Unobservable

Inputs

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

      Money market funds (1)

 

$

4,161

 

 

$

 

 

$

 

 

$

4,161

 

 

 

 

Fair Value Measurements at December 31, 2015 Using

 

 

 

Quoted Prices in

Active Markets for

Identical Assets

 

 

Significant Other

Observable

Inputs

 

 

Significant

Unobservable

Inputs

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds (1)

 

$

42,590

 

 

$

 

 

$

 

 

$

42,590

 

Marketable securities

 

 

496

 

 

 

 

 

 

 

 

 

496

 

Total

 

$

43,086

 

 

$

 

 

$

 

 

$

43,086

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent warrant liabilities

 

$

 

 

$

 

 

$

10,464

 

 

$

10,464

 

 

(1) Included in cash and cash equivalents

 

Summary of Estimated Fair Value Assumptions of Contingent Warrant Liabilities

The estimated fair value of the contingent warrant liabilities was estimated using the following range of assumptions at December 31, 2016 and 2015:

 

 

 

December 31,

 

 

2016

 

 

2015

Expected volatility

 

 

64%

 

 

166% - 183%

Risk-free interest rate

 

 

0.51%

 

 

0.64% - 0.74%

Expected term (in years)

 

0.19

 

 

0.94 - 1.19

 

Summary of Changes in Fair Value of Level 3 Financial Liabilities

The following table provides a summary of changes in the fair value of the Company’s Level 3 financial liabilities for the years ended December 31, 2016 and 2015 (in thousands):

 

Balance at December 31, 2014

 

$

31,828

 

Reclassification of contingent warrant liability to equity upon

   exercise of warrants

 

 

(3,552

)

Decrease in estimated fair value of contingent warrant liabilities

   upon revaluation

 

 

(17,812

)

Balance at December 31, 2015

 

 

10,464

 

Decrease in estimated fair value of contingent warrant liabilities

   upon revaluation

 

 

(10,464

)

Balance at December 31, 2016

 

$

 

 

Outstanding Debt Carrying Amount and Estimated Fair Value

The carrying amount and the estimated fair value of the Company’s outstanding interest-bearing obligations at December 31, 2016 and 2015 are as follows (in thousands):

 

 

 

December 31, 2016

 

 

December 31, 2015

 

 

 

Carrying Amount

 

 

Fair Value

 

 

Carrying Amount

 

 

Fair Value

 

Hercules term loan

 

$

16,850

 

 

$

16,453

 

 

$

19,653

 

 

$

21,231

 

Servier loan

 

 

12,231

 

 

 

12,242

 

 

 

15,331

 

 

 

15,185

 

Novartis note

 

 

14,086

 

 

 

13,836

 

 

 

13,683

 

 

 

13,394

 

Total interest bearing obligations

 

$

43,167

 

 

$

42,531

 

 

$

48,667

 

 

$

49,810